FDA Approved: HYCAMTIN — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for HYCAMTIN (topotecan hydrochloride) submitted by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Ovarian Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Hycamtin (Topotecan)

Snippet

SUPPL AP for HYCAMTIN (TOPOTECAN HYDROCHLORIDE)